Malignant Tumours of the Central Nervous System in Kazakhstan - Incidence Trends from 2004-2011

  • Igissinov, Nurbek (Central Asia Cancer Institute) ;
  • Akshulakov, Serik (Republican Research center of Neurosurgery) ;
  • Igissinov, Saginbek (Central Asia Cancer Institute) ;
  • Moore, Malcolm (UICC Asian Regional Office for Cancer Control) ;
  • Adilbekov, Yerzhan (Republican Research center of Neurosurgery) ;
  • Gaitova, Kamilla (Astana Medical University) ;
  • Kissaev, Yermek (Republican Research center of Neurosurgery) ;
  • Mustafina, Meruert (Astana Medical University)
  • Published : 2013.07.30


In the article were observed the epidemiological aspects of malignant tumors of the central nervous system (MT CNS) in Kazakhstan in a retrospective study for the years 2004-2011. The material of the study was consolidated accounting data of oncology centers on patients with MT CNS (C70-72) with first time established diagnosis. Calculated were crude, age, standardized (world standard), aligned and predicted incidence of MT CNS among both male and female populations. It was found that over the studied period, there were 4,604 cases of MT CNS. The average annual crude incidence rate of MT CNS in total population was $3.7{\pm}0.1^0/_{0000}$. Trends in aligned incidence rates in the whole country had a tendency to increase (T=+0.9%). Defined levels of morbidity MT CNS in the whole population in different regions of Kazakhstan: low up to $2.87^0/_{0000}$, the average from 2.87 to $4.45^0/_{0000}$ and high from $4.45^0/_{0000}$ and above on the basis of which was given the space-time estimate. Age and sex differences in MT CNS incidence were also clearly established.


CNS malignancies;incidence;age;gender;trends;cartograms;Kazakhstan


  1. American Cancer Society (2009). Cancer facts and figures 2008, American Cancer Society, Atlanta. Available from:
  2. Arora RS, Alston RD, Eden TO, et al (2010). Are reported increases in incidence of primary CNS tumours real? An analysis of longitudinal trends in England, 1979-2003. Eur J Cancer, 46, 1607-16.
  3. Aydin D, Feychting M, Schuz J, Roosli M; CEFALO study team (2012). Childhood brain tumours and use of mobile phones: comparison of a case-control study with incidence data. Environ Health, 11, 35.
  4. Barchana M, Margaliot M, Liphshitz I (2012). Changes in brain glioma incidence and laterality correlates with use of mobile phones--a nationwide population based study in Israel. Asian Pac J Cancer Prev, 13, 5857-63.
  5. Badar F, Mahmood S, Zaidi A, Bhurgri Y (2009). Age-standardized incidence rates for childhood cancers at a cancer hospital in a developing country. Asian Pac J Cancer Prev, 10, 753-8.
  6. Baldi I, Gruber A, Alioum A, et al (2011). Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007. Neuro Oncol, 13, 1370-8.
  7. Benson VS, Pirie K, Schuz J, et al for the Million Women Study Collaborators (2013). Mobile phone use and risk of brain neoplasms and other cancers: prospective study. Int J Epidemiol, 42, 792-802.
  8. Berg G, Spallek J, Schuz J, et al Interphone Study Group, Germany. (2006). Occupational exposure to radio frequency/microwave radiation and the risk of brain tumors: Interphone Study Group, Germany. Am J Epidemiol, 164, 538-48.
  9. Braganza MZ, Kitahara CM, Berrington de Gonzalez A, et al (2012). Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review. Neuro Oncol, 14, 1316-24.
  10. Bhurgri Y, Bhurgri H, Kayani N, et al (2011). Trends and morphology of central nervous system malignancies in Karachi. Asian Pac J Cancer Prev, 12, 2013-7
  11. Chen YH, Keller JJ, Kang JH, Lin HC (2012). Association between traumatic brain injury and the subsequent risk of brain cancer. J Neurotrauma, 29, 1328-33.
  12. Davydov MI, Aksel EM (2009). Cancer statistics in Russia and the CIS in 2007. J N N Blokhin Russian Cancer Re Centre RAMS, 20, 158.
  13. Dietrich M, Block G, Pogoda JM, et al (2005). A review: dietary and endogenously formed N-nitroso compounds and risk of childhood brain tumors. Cancer Causes Control, 16, 619-35.
  14. Ding LX, Wang YX (2011). Increasing incidence of brain and nervous tumours in urban Shanghai, China, 1983-2007. Asian Pac J Cancer Prev, 12, 3319-22.
  15. Dobes M, Khurana VG, Shadbolt B, et al (2011). Increasing incidence of glioblastoma multiforme and meningioma, and decreasing incidence of Schwannoma (2000-2008): Findings of a multicenter Australian study. Surg Neurol Int, 2, 176.
  16. Dubrow R, Darefsky AS, Freedman ND, Hollenbeck AR, Sinha R (2012). Coffee, tea, soda, and caffeine intake in relation to risk of adult glioma in the NIH-AARP Diet and Health Study. Cancer Causes Control, 23, 757-68.
  17. Dubrow R, Darefsky AS, Park Y, et al (2010). Dietary components related to N-nitroso compound formation: a prospective study of adult glioma. Cancer Epidemiol Biomarkers Prev, 19, 1709-22.
  18. Garcia-Sevilla JA, Escriba PV, Guimon J (1999) Imidazoline receptors and human brain disorders. Ann N Y Acad Sci, 881, 392-409.
  19. Glantz S (1999). Medical-biological statistics. Monograph, Moscow, 460 pp.
  20. Goske M, Applegate K, Frush D, Schulman MH, Morrison G (2012). CT scans in childhood and risk of leukaemia and brain tumours. Lancet, 380, 1737-8.
  21. IARC (2010). GLOBOCAN 2008: Cancer incidence and Mortality Worldwide in 2008: IARC CancerBase No. 10. Available from: Accessed: July 29, 2011.
  22. Igissinov N, Igissinov S, Moore MA, et al (2011). Trends of prevalent cancer incidences in the Aral-Syr Darya ecological area of Kazakhstan. Asian Pac J Cancer Prev, 12, 2299-303.
  23. Igissinov N, Zatoskikh V, Moore MA, et al (2013). Epidemiological evaluation of laryngeal cancer incidence in Kazakhstan for the years 1999-2009. Asian Pac J Cancer Prev, 14, 3969-74.
  24. Ishmatov RF (2013). Brain tumours: analysis of epidemiology and neuro-oncology service status in the Ul'ianovsk region. Zh Vopr Neirokhir Im N N Burdenko, 77, 62-5.
  25. Kesari KK, Siddiqui MH, Meena R, Verma HN, Kumar S (2013). Cell phone radiation exposure on brain and associated biological systems. Indian J Exp Biol, 51, 187-200.
  26. Kim RK, Suh Y, Cui YH, et al (2013). Fractionated radiation-induced nitric oxide promotes expansion of glioma stem-like cells. Cancer Sci, [Epub ahead of print].
  27. Kleinerman RA, Linet MS, Hatch EE, et al (2005). Self-reported electrical appliance use and risk of adult brain tumors. Am J Epidemiol, 161, 136-46.
  28. Lannering B, Sandstrom PE, Holm S, et al (2009). Classification, incidence and survival analyses of children with CNS tumours diagnosed in Sweden 1984-2005. Acta Paediatr, 98, 1620-7.
  29. Little MP, Rajaraman P, Curtis RE, et al (2012). Mobile phone use and glioma risk: comparison of epidemiological study results with incidence trends in the United States. BMJ, 344, e1147.
  30. Maschio M (2012). Brain tumor-related epilepsy. Curr Neuropharmacol, 10, 124-33.
  31. MEPs against cancer (2011). Cancer facts and figures. Available from:
  32. Merkov AM, Polykov LE (1974). Sanitary statistics. Monograph, Leningrad, 384 pp.
  33. Nomura E, Ioka A, Tsukuma H (2011). Okada H, Scheurer ME, Sarkar SN, Bondy ML (2013). Integration of epidemiology, immunobiology, and translational research for brain tumors. Ann N Y Acad Sci, 1284, 17-23.
  34. Ortega-Garcia JA, Lopez-Hernandez FA, Fuster-Soler JL, Martinez-Lage JF (2011). Space-time clustering in childhood nervous system tumors in the Region of Murcia, Spain, 1998-2009. Childs Nerv Syst, 27, 1903-11.
  35. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108.
  36. Plascak JJ, Fisher JL (2013). Area-based socioeconomic position and adult glioma: a hierarchical analysis of surveillance epidemiology and end results data. PLoS One, 8, 60910.
  37. Qian X, Cheng YH, Mruk DD, Cheng CY (2013). Breast cancer resistance protein (Bcrp) and the testis-an unexpected turn of events. Asian J Androl, [Epub ahead of print].
  38. Rivera M, Sukhdeo K, Yu J (2013). Ionizing radiation in glioblastoma initiating cells. Front Oncol, 3, 74.
  39. Rosychuk RJ, Witol A, Wilson B, Stobart K (2012). Central nervous system (CNS) tumor trends in children in a western Canadian province: a population-based 22-year retrospective study. J Neurol, 259, 1131-6.
  40. Ruder AM, Yiin JH, Waters MA, et al Brain Cancer Collaborative Study Group (2013). The Upper Midwest health study: gliomas and occupational exposure to chlorinated solvents. Occup Environ Med, 70, 73-80.
  41. Schmidt LS, Schmiegelow K, Lahteenmaki P, et al (2011). Incidence of childhood central nervous system tumors in the Nordic countries. Pediatr Blood Cancer, 56, 65-9.
  42. van Tongeren M, Kincl L, Richardson L, et al INTEROCC STUDY GROUP (2013). Assessing occupational exposure to chemicals in an international epidemiological study of brain tumours. Ann Occup Hyg, 57, 610-26.
  43. Vijayalaxmi, Prihoda TJ (2012). Genetic damage in human cells exposed to non-ionizing radiofrequency fields: a meta-analysis of the data from 88 publications (1990-2011). Mutat Res, 749, 1-16.
  44. World Health Organization Statistical information System (2011). WHO mortality database. Available from:
  45. Woehrer A (2013). Brain tumor epidemiology in Austria and the Austrian brain tumor registry. Clin Neuropathol, 32, 269-85.
  46. Wu J, Ji Z, Liu H, et al (2013). Arsenic trioxide depletes cancer stem-like cells and inhibits repopulation of neurosphere derived from glioblastoma by downregulation of Notch pathway. Toxicol Lett, 220, 61-9.
  47. Wu QJ, Vogtmann E, Zhang W, et al (2012). Cancer incidence among adolescents and young adults in urban Shanghai, 1973-2005. PLoS One, 7, e42607.
  48. Yamaguchi N (2013). The IARC carcinogenicity evaluation of radio-frequency electromagnetic field: with special reference to epidemiology of mobile phone use and brain tumor risk. Nihon Eiseigaku Zasshi, 68, 78-82.
  49. Yang JH, Wu SL (2007). Multiple sclerosis preceding CNS lymphoma: a case report. Acta Neurol Taiwan, 16, 92-7.
  50. Yeole BB (2008) Trends in the brain cancer incidence in India. Asian Pac J Cancer Prev, 9, 267-70.
  51. Zada G, Bond AE, Wang YP, Giannotta SL, Deapen D (2012). Incidence trends in the anatomic location of primary malignant brain tumors in the United States: 1992-2006. World Neurosurg, 77, 518-24.
  52. Zaridze DG (2002). Epidemiology, mechanisms of cancer genesis and prevention. Arch Pathol, 2, 53-61.

Cited by

  1. One-year Survival Rate of Patients with Primary Malignant Central Nervous System Tumors after Surgery in Kazakhstan vol.15, pp.16, 2014,
  2. Correlation of Breast Cancer Incidence with the Number of Motor Vehicles and Consumption of Gasoline in Korea vol.15, pp.7, 2014,
  3. Malignant Tumors of the Central Nervous System in Kazakhstan: Component Analysis of Incidence Dynamics vol.16, pp.6, 2015,
  4. Cancer Incidence and Mortality Data in Aktobe, West Kazakhstan, 2000-2010 vol.16, pp.6, 2015,
  5. Introduction of Questionnaires for Quality of Life of Patients with Malignant Tumors of the Central Nervous System into Neurosurgical Practice in the Republic of Kazakhstan vol.17, pp.2, 2016,
  6. Glioblastoma recurrence correlates with NLGN3 levels vol.7, pp.7, 2018,